These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11744689)
41. Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells. Lee EK; Lee YS; Han IO; Park SH Biochem Biophys Res Commun; 2007 Jul; 359(2):385-90. PubMed ID: 17543885 [TBL] [Abstract][Full Text] [Related]
42. Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. Kurtev V; Margueron R; Kroboth K; Ogris E; Cavailles V; Seiser C J Biol Chem; 2004 Jun; 279(23):24834-43. PubMed ID: 15140878 [TBL] [Abstract][Full Text] [Related]
43. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines. Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467 [TBL] [Abstract][Full Text] [Related]
44. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Choi HS; Lee JH; Park JG; Lee YI Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149 [TBL] [Abstract][Full Text] [Related]
45. The transcription factor CCAAT-binding factor CBF/NF-Y and two repressors regulate the core promoter of the human pro-alpha3(V) collagen gene (COL5A3). Nagato H; Matsuo N; Sumiyoshi H; Sakata-Takatani K; Nasu M; Yoshioka H J Biol Chem; 2004 Nov; 279(45):46373-83. PubMed ID: 15316020 [TBL] [Abstract][Full Text] [Related]
46. The transcription factor CCAAT-binding factor CBF/NF-Y regulates the proximal promoter activity in the human alpha 1(XI) collagen gene (COL11A1). Matsuo N; Yu-Hua W; Sumiyoshi H; Sakata-Takatani K; Nagato H; Sakai K; Sakurai M; Yoshioka H J Biol Chem; 2003 Aug; 278(35):32763-70. PubMed ID: 12805369 [TBL] [Abstract][Full Text] [Related]
47. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Ashburner BP; Westerheide SD; Baldwin AS Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889 [TBL] [Abstract][Full Text] [Related]
48. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites. Lok CN; Lang AJ; Mirski SE; Cole SP Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834 [TBL] [Abstract][Full Text] [Related]
49. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. Caretti G; Salsi V; Vecchi C; Imbriano C; Mantovani R J Biol Chem; 2003 Aug; 278(33):30435-40. PubMed ID: 12771133 [TBL] [Abstract][Full Text] [Related]
50. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites. Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969 [TBL] [Abstract][Full Text] [Related]
51. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Hirose T; Sowa Y; Takahashi S; Saito S; Yasuda C; Shindo N; Furuichi K; Sakai T Oncogene; 2003 Oct; 22(49):7762-73. PubMed ID: 14586402 [TBL] [Abstract][Full Text] [Related]
52. Identification of a negative Cis-regulatory element and multiple DNA binding proteins that inhibit transcription of the transforming growth factor-beta type II receptor gene. Song SU; Oh IS; Lee B; Suh JK; Kim JH; Cha YD; Lee KH; Kim DH Gene; 2001 Jan; 262(1-2):179-87. PubMed ID: 11179682 [TBL] [Abstract][Full Text] [Related]
53. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression. Park SH; Kim YS; Park BK; Hougaard S; Kim SJ Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868 [TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Kanai H; Tanaka T; Aihara Y; Takeda S; Kawabata M; Miyazono K; Nagai R; Kurabayashi M Circ Res; 2001 Jan; 88(1):30-6. PubMed ID: 11139470 [TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells. Tarakanova VL; Wold WS J Virol; 2003 Sep; 77(17):9324-36. PubMed ID: 12915548 [TBL] [Abstract][Full Text] [Related]
56. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Glaser KB; Staver MJ; Waring JF; Stender J; Ulrich RG; Davidsen SK Mol Cancer Ther; 2003 Feb; 2(2):151-63. PubMed ID: 12589032 [TBL] [Abstract][Full Text] [Related]
57. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. Senawong T; Peterson VJ; Avram D; Shepherd DM; Frye RA; Minucci S; Leid M J Biol Chem; 2003 Oct; 278(44):43041-50. PubMed ID: 12930829 [TBL] [Abstract][Full Text] [Related]
58. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer. Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502 [TBL] [Abstract][Full Text] [Related]
59. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829 [TBL] [Abstract][Full Text] [Related]
60. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. Jee YK; Gilmour J; Kelly A; Bowen H; Richards D; Soh C; Smith P; Hawrylowicz C; Cousins D; Lee T; Lavender P J Biol Chem; 2005 Jun; 280(24):23243-50. PubMed ID: 15826950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]